Encompass Health (NYSE:EHC – Free Report) had its target price raised by Truist Financial from $82.00 to $86.00 in a research note released on Friday, Benzinga reports. They currently have a buy rating on the stock.
Other equities analysts have also issued research reports about the company. Mizuho lifted their price objective on Encompass Health from $77.00 to $82.00 and gave the company a buy rating in a research note on Friday. Stephens reiterated an overweight rating and issued a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. William Blair restated an outperform rating on shares of Encompass Health in a report on Wednesday, February 7th. Finally, Royal Bank of Canada reaffirmed an outperform rating and set a $83.00 price target on shares of Encompass Health in a research report on Friday. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of Buy and an average price target of $79.89.
Encompass Health Stock Up 0.8 %
Institutional Trading of Encompass Health
Hedge funds have recently bought and sold shares of the company. TFO Wealth Partners LLC increased its stake in Encompass Health by 39,783.3% during the 4th quarter. TFO Wealth Partners LLC now owns 2,393 shares of the company’s stock worth $160,000 after buying an additional 2,387 shares during the period. Treasurer of the State of North Carolina boosted its holdings in shares of Encompass Health by 68.5% in the 4th quarter. Treasurer of the State of North Carolina now owns 81,452 shares of the company’s stock valued at $5,434,000 after buying an additional 33,113 shares during the period. Allianz Asset Management GmbH boosted its stake in Encompass Health by 701.7% during the 4th quarter. Allianz Asset Management GmbH now owns 192,350 shares of the company’s stock valued at $12,834,000 after purchasing an additional 168,358 shares during the period. Stifel Financial Corp boosted its stake in Encompass Health by 3.9% during the 4th quarter. Stifel Financial Corp now owns 50,360 shares of the company’s stock valued at $3,360,000 after purchasing an additional 1,882 shares during the period. Finally, TD Asset Management Inc boosted its stake in Encompass Health by 239.6% during the 4th quarter. TD Asset Management Inc now owns 1,969,186 shares of the company’s stock valued at $131,384,000 after purchasing an additional 1,389,275 shares during the period. Institutional investors and hedge funds own 92.66% of the company’s stock.
Encompass Health Company Profile
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
- Five stocks we like better than Encompass Health
- What is a Stock Market Index and How Do You Use Them?
- 3 attractive stocks that insiders are buying
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.